O-099 XYOTAX™ vs. docetaxel for the second-line treatment...

Lung Cancer 2005 / 7 Vol. 49

O-099 XYOTAX™ vs. docetaxel for the second-line treatment of non-small cell lung cancer (NSCLC): The STELLAR 2 phase III study

Bonomi, P., Paz-Ares, L., Langer, C., O'Brien, M., Gervais, R., Gatzemeier, U., Reiterer, P., Orlov, S., Ross, H., Vandenbulcke, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(05)80233-8
Date:
July, 2005
File:
PDF, 131 KB
english, 2005
Conversion to is in progress
Conversion to is failed